The Short Answer
Tempus AI stock (TEM) is currently classified as HALAL in the qualitative catalog, but its March 31, 2026 filing-based quantitative result does not pass. Precision medicine and diagnostics are generally permissible; the current balance sheet fails the asset-based debt screen.
Current quantitative Sharia screen
Based on 10-Q figures for the period ended 2026-03-31; calculated 2026-07-15.
1,318.532 / 2,135.091
521.17 / 2,135.091
829.769 / 2,135.091
3.866 / 348.116
- Financial
- Fails
- Overall
- Fails
Debt/assets is 61.76%, above the examined 33.333% limit; liquidity/assets is 24.41%, receivables-plus-cash/assets is 38.86% and disclosed interest income is 1.11%.
- Financial
- Fails
- Overall
- Fails
Debt/assets is 61.76% and receivables-plus-cash/assets is 38.86%, above the examined MSCI limits; liquidity/assets is 24.41%.
- Financial
- Fails
- Overall
- Fails
Debt/assets is 61.76%, above the examined Malaysia limit; liquidity/assets is 24.41%. This is not an official classification.
- Financial
- Not calculated
- Overall
- Fails
A licensed historical market-cap series is not stored; the total-assets debt screen already fails.
Business-activity disclosure
Tempus provides AI-enabled precision medicine, genomic diagnostics, clinical data and software. These healthcare activities are generally permissible, while customer, clinical and data-use allocation remains qualitative.
Limitation: The filing does not allocate revenue into a universal prohibited-activity numerator by customer use, clinical workflow or data-license purpose.
Purification
Tempus discloses $3.866 million of interest income, but no scholar-specific purification percentage or universal prohibited-revenue numerator is provided.
Inputs, assumptions and primary sources
- Amounts are USD millions from Tempus AI's March 31, 2026 Form 10-Q.
- Debt includes the $199.279 million convertible promissory note, $100.000 million revolving credit facility, $204.624 million long-term debt, $729.267 million convertible senior notes and $85.362 million of operating-lease liabilities.
- Cash and cash equivalents are $521.170 million. The $117.902 million marketable-equity-securities balance is not treated as an interest-bearing security.
- Accounts receivable, net are $308.599 million and first-quarter revenue is $348.116 million.
- The filing separately discloses $3.866 million of interest income, approximately 1.11% of quarterly revenue.
- Precision medicine, diagnostics, clinical data and decision-support software are generally permissible, but no universal prohibited-revenue numerator is disclosed.
This is a reproducible financial screen, not a fatwa. A failed total-assets screen can coexist with a pass under a market-cap methodology. ZakatInvest keeps the qualitative assessment separate so numerical thresholds do not erase material context.
The filing reports debt/assets of 61.76%, liquidity/assets of 24.41%, receivables plus cash/assets of 38.86%, and interest income of 1.11% of quarterly revenue. Debt fails even though the disclosed interest-income ratio is below 5%.
Sharia Screening Methodology
Islamic scholars use several criteria to screen stocks:
- Business activity screen: Is the company's primary business halal?
- Debt ratio: Total debt / market cap must be under 33%
- Interest income: Interest income / total revenue must be under 5%
- Haram revenue: Revenue from haram sources must be under 5%
- Receivables ratio: Total receivables / total assets must be under 49–70% (varies by board)
Tempus AI's Business Activity
Tempus AI, Inc. provides AI-enabled precision-medicine products. Its revenue comes from:
- Genomics: Sequencing and diagnostic testing, particularly in oncology
- Data and services: Licensing a large library of clinical and molecular data
- Software: Tools that help physicians personalize treatment
Healthcare diagnostics, clinical data, and decision-support software are permissible activities with no inherent haram revenue line.
Why TEM Is Halal
1. Permissible Core Business
Precision medicine and diagnostics are halal activities that benefit patients. There is no gambling, alcohol, conventional banking, or other prohibited line at the heart of the business.
2. Manageable Leverage — Verify
Tempus carries $1,318.532 million of debt and operating leases against $2,135.091 million of assets. The asset-based debt ratio is 61.76%, above the examined 33.333% limits; market-cap methods are not calculated without a licensed historical series.
3. Interest Income
The filing discloses $3.866 million of interest income, or 1.11% of quarterly revenue. No fixed purification percentage is asserted, and the activity screen remains qualitative.
Filing-Based Ratios (March 31, 2026)
Based on Tempus AI's latest Form 10-Q:
- Debt / Total Assets: 61.76% — above examined limits ⚠️
- Liquidity / Total Assets: 24.41% ✅
- Receivables + Cash / Total Assets: 38.86% — above the examined MSCI limit ⚠️
- Disclosed Interest Income / Revenue: 1.11% ✅
- Prohibited-Product Revenue: No universal numerator disclosed — qualitative review required ⚠️
Methodology Interpretation
The current filing-based screen fails on debt/assets under the examined FTSE, MSCI and Malaysia-style limits. Precision medicine remains generally permissible, but clinical data use, customer mix and purification treatment require review.
- Core activity: Genomics, diagnostics, clinical data and software
- Quantitative status: Debt fails; liquidity and disclosed income pass
- Scholar review: Confirm data-use and downstream healthcare treatment
Bottom Line
Tempus AI (TEM) has a generally permissible core activity and remains classified as HALAL in the qualitative catalog, but the current filing-based result is not passing because debt/assets is 61.76%. The disclosed interest-income ratio is 1.11%, while clinical data use and downstream customer exposure remain qualitative review topics.
For Muslim investors seeking healthcare and AI exposure, compare TEM with peers like Recursion Pharmaceuticals (RXRX) and NVIDIA (NVDA).
Want to check if another stock is halal? Use our free screener.
Open Halal Checker →